Skip to content
CancerIndex

Publication

Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.

Authors not recorded

Blood2017PMID 28408464PMC5482101stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (23)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 23

Curated evidence

Evidence citing this paper (21)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
28408464
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–21 of 21 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
ABL2 Fusion1
(oncogenic)B Lymphoblastic Leukemia/LymphomaCURATED_BROADEROncogenicCSupports Oncogenicity2submitted
EID9771

In a study of 1389 consecutively enrolled, newly diagnosed patients with B-ALL, two male patients with high risk Ph-like disease were identified to carry RCSD1-ABL2 fusion by RT-PCR and are eligible t… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
JAK2 Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive4accepted
EID7698

In this study which included 1389 cases of high-risk pediatric B-ALL, 284 were identified by TaqMan Low Density Array to have a Ph-like gene expression signature. RT-PCR or RNAseq performed on the 129… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
ABL1 Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive2accepted
EID9078

This study included 1389 cases of high-risk pediatric B-ALL, of which 284 were identified by TaqMan Low Density Array to have a BCR-ABL1-like (Ph-like) gene expression signature. RT-PCR or RNAseq perf… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
JAK2 Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive4accepted
EID8102

In this study which included 1389 cases of high-risk pediatric B-ALL, 284 were identified by TaqMan Low Density Array to have a Ph-like gene expression signature. RT-PCR or RNAseq performed on CRLF2 n… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
NTRK3 Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive1submitted
EID12295

Philadelphia chromosome-like (Ph-like) acute lymphoblastic leukemia (ALL) is a high-risk subtype characterised by genomic alterations that activate cytokine receptor and kinase signaling. The author e… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
CRLF2 Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive4accepted
EID8233

Among 284 cases with Ph-like expression signature who were identified by testing 1389 high-risk cases of pediatric B-ALL, overexpression and rearrangement of CRLF2 were identified in 124 (43.7%). This… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
ABL1 Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive2accepted
EID9080

This retrospective study included 1389 cases of high-risk pediatric B-ALL, of which 284 were identified by TaqMan Low Density Array to have a BCR-ABL1-like (Ph-like) gene expression signature. RT-PCR … (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
ABL1 Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive2accepted
EID9079

This study included 1389 cases of high-risk pediatric B-ALL, of which 284 were identified by TaqMan Low Density Array to have a BCR-ABL1-like (Ph-like) gene expression signature. RT-PCR or RNAseq perf… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
JAK2 Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive3accepted
EID7700

In this study which included 1389 cases of high-risk pediatric B-ALL, 284 were identified by TaqMan Low Density Array to have a Ph-like gene expression signature. RT-PCR or RNAseq performed on CRLF2 n… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
JAK2 Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive3accepted
EID7704

The PCM1-JAK2 fusion is typically associated with 'myeloid/lymphoid neoplasms with eosinophilia and gene rearrangements', which is a specific disease entity according to WHO classification. However, i… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
ABL1 Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive2accepted
EID9076

This study included 1389 cases of high-risk pediatric B-ALL, of which 284 were identified by TaqMan Low Density Array to have a Ph-like gene expression signature. RT-PCR or RNAseq performed on Ph-like… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
ABL1 Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive2accepted
EID9075

This study included 1389 cases of high-risk pediatric B-ALL, of which 284 were identified by TaqMan Low Density Array to have a Ph-like gene expression signature. RT-PCR or RNAseq performed on Ph-like… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
JAK2 Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive3accepted
EID7707

This study included 1389 cases of high-risk pediatric B-ALL, out of which 284 were identified by TaqMan Low Density Array to have a Ph-like gene expression signature. RT-PCR or RNAseq performed on the… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
CSF1R Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticBSupports Positive2submitted
EID9803

A multicenter, retrospective study that included 1389 consecutively enrolled, newly diagnosed patients with B-lineage acute lymphoblastic leukemia (B-ALL). There were 3 patients that harbored SSPB2-CS… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
JAK2 Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive4accepted
EID8103

In this study which included 1389 cases of high-risk pediatric B-ALL, 284 were identified by TaqMan Low Density Array to have a Ph-like gene expression signature. RT-PCR or RNAseq performed on CRLF2 n… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
CSF1R Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive3accepted
EID9361

This study included 1389 cases of high-risk pediatric B-ALL, of which 284 were identified by TaqMan Low Density Array to have a BCR-ABL1-like (Ph-like) gene expression signature. RT-PCR or RNAseq perf… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
JAK2 Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive3accepted
EID7705

In B-lymphoblastic leukemia/lymphoma (B-ALL), the presence of this fusion is associated with so-called BCR/ABL1 like (Ph-like) subtype of the disease. The USP25-JAK2 fusion is rare; this study involve… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
LYN Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive3accepted
EID12801

In this 2017 study, the authors characterized 284 cases of Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) identified from a cohort of 1,389 pediatric patients with high-risk B… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
ABL1 Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive2accepted
EID9077

This study included 1389 cases of high-risk pediatric B-ALL, of which 284 were identified by TaqMan Low Density Array to have a BCR-ABL1-like (Ph-like) gene expression signature. RT-PCR or RNAseq perf… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
JAK2 Fusion1
(diagnostic)B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-LikeDiagnosticCSupports Positive3accepted
EID7706

This study included 1389 cases of high-risk pediatric B-ALL, out of which 284 were identified by TaqMan Low Density Array to have a Ph-like gene expression signature. RT-PCR or RNAseq performed on the… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic
CRLF2 Fusion1
(diagnostic)Childhood B-cell Acute Lymphoblastic LeukemiaUNRESOLVEDDiagnosticCSupports Positive4submitted
EID6230

Among 284 cases with Ph-like expression signature who were identified by testing 1389 high-risk cases of pediatric B-ALL, overexpression and rearrangement of CRLF2 (IGH-CRLF2 or P2RY8-CRLF2) were id… (full text at CIViC)

PMID 28408464 · Reshmi et al., 2017 · Open in CIViC

civic